AP2910A - Novel use of antihistamine agents for the preventative or early treatment of inflammatory syndromes,in particular those triggered by togaviruses - Google Patents

Novel use of antihistamine agents for the preventative or early treatment of inflammatory syndromes,in particular those triggered by togaviruses

Info

Publication number
AP2910A
AP2910A AP2008004613A AP2008004613A AP2910A AP 2910 A AP2910 A AP 2910A AP 2008004613 A AP2008004613 A AP 2008004613A AP 2008004613 A AP2008004613 A AP 2008004613A AP 2910 A AP2910 A AP 2910A
Authority
AP
ARIPO
Prior art keywords
togaviruses
preventative
particular those
early treatment
novel use
Prior art date
Application number
AP2008004613A
Other languages
English (en)
Other versions
AP2008004613A0 (en
Inventor
Jean Derengnaucourt
Etienne Andre
Jacky Tisne-Versailles
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of AP2008004613A0 publication Critical patent/AP2008004613A0/xx
Application granted granted Critical
Publication of AP2910A publication Critical patent/AP2910A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2008004613A 2006-03-09 2007-03-09 Novel use of antihistamine agents for the preventative or early treatment of inflammatory syndromes,in particular those triggered by togaviruses AP2910A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0602087A FR2898271B1 (fr) 2006-03-09 2006-03-09 Nouvelle utilisation d'agents antihistaminiques pour le traitement preventif ou procede de syndromes inflammatoires, en particulier ceux declenches par les toga virus.
PCT/EP2007/052237 WO2007101884A1 (fr) 2006-03-09 2007-03-09 Nouvelle utilisation d'agents antihistaminiques pour le traitement preventif ou precoce de syndromes inflammatoires, en particulier ceux declenches par les togavirus.

Publications (2)

Publication Number Publication Date
AP2008004613A0 AP2008004613A0 (en) 2008-10-31
AP2910A true AP2910A (en) 2014-05-31

Family

ID=37075926

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004613A AP2910A (en) 2006-03-09 2007-03-09 Novel use of antihistamine agents for the preventative or early treatment of inflammatory syndromes,in particular those triggered by togaviruses

Country Status (11)

Country Link
US (1) US8242110B2 (de)
EP (1) EP2007394B1 (de)
JP (1) JP5550836B2 (de)
KR (1) KR101450345B1 (de)
CN (1) CN101394854A (de)
AP (1) AP2910A (de)
BR (1) BRPI0709006A2 (de)
FR (1) FR2898271B1 (de)
MX (1) MX2008011454A (de)
WO (1) WO2007101884A1 (de)
ZA (1) ZA200807442B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2386734T3 (es) 2005-12-22 2012-08-28 High Point Pharmaceuticals, Llc Ácidos fenoxiacéticos como activadores de PPAR-DELTA
CN102028692B (zh) * 2010-12-01 2012-08-22 中国人民解放军第二军医大学 酮色林的应用
CN103690522B (zh) * 2013-12-08 2015-05-06 武汉威立得生物医药有限公司 一种草酸萘呋胺在制备治疗或预防流感病毒药物中的应用
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US11426408B2 (en) * 2017-11-01 2022-08-30 National University Of Singapore Use of serotonergic drugs to treat virus-induced thrombocytopenia
WO2020212952A1 (en) 2019-04-17 2020-10-22 Compass Pathfinder Limited Treatment of depression and other various disorders with psilocybin
US11071739B1 (en) 2020-09-29 2021-07-27 Genus Lifesciences Inc. Oral liquid compositions including chlorpromazine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3726976A (en) * 1968-03-20 1973-04-10 J Glasser Treatment of arthritis with combinations of antihistaminic compounds and diuretics
JPH0489428A (ja) * 1990-07-30 1992-03-23 Kao Corp 多形核白血球活性化剤
US5492689A (en) * 1991-11-19 1996-02-20 The Center For Innovative Technology Combined virustatic antimediator (COVAM) treatment of common colds
JPH08239327A (ja) * 1995-03-03 1996-09-17 Taisho Pharmaceut Co Ltd 慢性骨格筋疼痛の予防又は治療剤
JP2001151677A (ja) 1999-11-26 2001-06-05 Taisho Pharmaceut Co Ltd 咽頭用組成物
FR2802101B1 (fr) * 1999-12-10 2003-02-28 Aventis Pharma Sa Association de cymemazine et d'un neuroleptique atypique

Also Published As

Publication number Publication date
WO2007101884A1 (fr) 2007-09-13
BRPI0709006A2 (pt) 2011-06-21
JP2009529514A (ja) 2009-08-20
EP2007394A1 (de) 2008-12-31
FR2898271B1 (fr) 2009-01-16
AP2008004613A0 (en) 2008-10-31
CN101394854A (zh) 2009-03-25
KR20080107410A (ko) 2008-12-10
EP2007394B1 (de) 2012-10-10
JP5550836B2 (ja) 2014-07-16
US8242110B2 (en) 2012-08-14
ZA200807442B (en) 2009-07-29
FR2898271A1 (fr) 2007-09-14
KR101450345B1 (ko) 2014-10-14
MX2008011454A (es) 2008-09-24
US20090069308A1 (en) 2009-03-12

Similar Documents

Publication Publication Date Title
DK2193097T3 (da) Nanostrukturforstærkede kompositartikler og fremgangsmåder
IL187999A0 (en) Compositions for the treatment of persistent infections
AP2910A (en) Novel use of antihistamine agents for the preventative or early treatment of inflammatory syndromes,in particular those triggered by togaviruses
PL3424932T3 (pl) Boronoftalidy do zastosowania terapeutycznego
IL189048A0 (en) Gsk-3 inhibitors
LTPA2018503I1 (lt) Kladribino režimas, skirtas išsėtinei sklerozei gydyti
PL2205720T3 (pl) Kompozycja do leczenia stwardnienia rozsianego
DE602006020069D1 (de) Mehrlagige flasche
IL230165A (en) Medications containing epa, dha or dha derived from epa for the treatment of cell oxidation damage pathology
ITMI20052085A1 (it) Tutore ambidestro per polso provvisto di immobilizzatore del pollice
EP1970063A4 (de) Therapeutisches mittel gegen diabetes
DE602006019395D1 (de) Media-behandlungseinrichtung
EP1973525A4 (de) Emulsionshaltige medizinische artikel
DK1971634T3 (da) Totrinshærdningspolymidoligomerer
ITMI20050393U1 (it) Impugnatura ribaltabile di sicurezza
ITRM20050179A1 (it) Composizione impiegabile per il trattamento delle patologie paradontali.
IL172896A0 (en) Cxcr4 inhibition
IL182055A0 (en) Agent for prophylaxis or treatment of metabolic syndrome
DE502006007174D1 (de) Chneidezähnen versehenen werkstücken
GB0511769D0 (en) Treatment
EP1878684A4 (de) Meldevorrichtung für aufzug
GB0520611D0 (en) Overflow preventative
AT502107A3 (de) Articles
TR200604882A3 (tr) Örülü esya imalati için tertibat.
GB0619344D0 (en) Safe reversing